Author

Pablo Sardi

Sanofi (United States)

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Genetic & Genomic Medicine· 1 Neuroscience· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Organism:human· 2 Assay:bulk RNA-seq· 1 Research Focus:differential expression· 1 Research Focus:drug response / drug discovery· 1 Approach:experimental assay· 1 Organism:mouse· 1 Approach:statistical model· 1

Frequent Co-Authors

Adil HarroudiD· 1 shared Amirhossein Rajabi Vajargah· 1 shared Ane Miren SalvadoriD· 1 shared Ayman IsmailiD· 1 shared Camille Lacarrière-Keïta· 1 shared Cécile Capdevila· 1 shared Cheryl WatersiD· 1 shared Chiara RapisardaiD· 1 shared

Activity by Year

2026-2026 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 20 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperGenetic & Genomic Medicine

Adil HarroudORCID

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

GALC variants affect Glucocerebrosidase to Galactosylceramidase activity ratio

Amirhossein Rajabi Vajargah, Konstantin A. Senkevich, Zhao Zhang, Lang Liu, Saeid Amiri, Morvarid Ghamgosar Shahkhali, Meron Teferra, Camille Lacarrière-Keïta, Pablo Sardi, Ming Sum Ruby Chiang, Cheryl Waters, Adil Harroud, Roy N. Alcalay, Thomas M. Durcan, Edward A. Fon, Ziv Gan‐Or

The paper examines how genetic variants in GALC affect the ratio of glucocerebrosidase to galactosylceramidase activity and its association with Parkinson's disease risk.

medRxiv · Oct 7, 2026 · PreprintGenetic & Genomic Medicine

pH-dependent anti-TfR1 NANOBODY(R) molecules deliver efficacious oligonucleotide payloads to muscle and CNS tissues

Emily A Hoyt, Kristof Moonens, Chiara Rapisarda, Ane Miren Salvador, Timothy R. Hammond, Sujay V. Kharade, Ricardo Mondragón-González, Faith Elaine Yuantiao Moran, Shruthi Ramkumar, Jayaprakash Thummapudi, Shan Zhou, Gilles Haussy, Cécile Capdevila, Fiona Maillard, Ayman Ismail, , Nina C. Leksa

This study develops anti-TfR1 NANOBODY(R) molecules that deliver siRNA and ASO payloads to muscle and CNS tissues, achieving significant mRNA knockdown.

bioRxiv · Aug 3, 2026 · PreprintNeuroscience